M

Mereo BioPharma Group plc
D

MREO

3.41000
USD
0.03
(0.89%)
مغلق
حجم التداول
20,910
الربح لكل سهم
-0
العائد الربحي
-
P/E
-11
حجم السوق
529,046,520
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADUS
    -2.080
    (-1.71%)
    119.760 USD
    A
    ARCT
    -2.310
    (-12.60%)
    16.020 USD
    C
    CTRA
    0.130
    (0.51%)
    25.555 USD
    E
    EVLO
    0
    (0%)
    0.000000 USD
    F
    FENC
    -0.42000
    (-9.52%)
    3.99000 USD
    G
    GH
    -1.065
    (-3.53%)
    29.130 USD
    J
    JAZZ
    -2.620
    (-2.11%)
    121.660 USD
    K
    KNSA
    -0.500
    (-2.29%)
    21.300 USD
    Z
    ZYXI
    -0.29300
    (-3.62%)
    7.79500 USD
    المزيد
الأخبار

العنوان: Mereo BioPharma Group plc

القطاع: Healthcare
الصناعة: Biotechnology
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).